Board Mtg Agenda - 06.07.2023 with panelists_0.pdf |
Board Mtg Agenda - 06.07.2023 with panelists_0.pdf
(214.6 KB)
|
|
|
|
Board Mtg Agenda - 06.07.2023 with panelists.pdf |
Board Mtg Agenda - 06.07.2023 with panelists.pdf
(213.53 KB)
|
|
|
|
Board Mtg Agenda - 06.07.2023_0.pdf |
Board Mtg Agenda - 06.07.2023_0.pdf
(206.34 KB)
|
|
|
|
Board Mtg Agenda - 06.07.2023.pdf |
Board Mtg Agenda - 06.07.2023.pdf
(206.35 KB)
|
|
|
|
Public Comment - Robert Hoffman - 06.05.2023.pdf |
Public Comment - Robert Hoffman - 06.05.2023.pdf
(264.71 KB)
|
|
|
|
OCVT_FY23_GMCB_ACO_Reporting_Manual.v.23.3.1_FINAL.pdf |
OCVT_FY23_GMCB_ACO_Reporting_Manual.v.23.3.1_FINAL.pdf
(1.1 MB)
|
|
|
|
Pricing Transparency - DVHA - Top Drugs CY 2022 |
Copy of DVHA_TOP_DRUGS_CY2022-Pricing Transparency_FINAL_05.31.23.pdf
(97.15 KB)
|
Publication |
|
PDF |
Pharma Transparency 18 V.S.A. § 4635 - CY2022 |
18 V.S.A. § 4635- Pricing Transparency Drug List-DVHA Methodology_CY2022FINAL.pdf
(300.41 KB)
|
Publication |
|
PDF |
appendix_exhibits_9_10_11- updated 6-2-23 |
appendix_exhibits_9_10_11 updated 2023_06_02.pdf
(83.96 KB)
|
|
|
PDF |
UVMHN and DMH Letter to GMCB - 05.31.2023 |
UVMHN and DMH letter to GMCB re mental health investments - 05.31.23.pdf
(383.08 KB)
|
Report |
|
PDF |